Jack E. Henningfield

Jack E. Henningfield, PhD, is Vice President, Research, Health Policy, and Abuse Liability at Pinney Associates, and Adjunct Professor, Behavioral Biology, Department of Psychiatry and Behavioral Sciences, at the Johns Hopkins University School ofMedicine. His research and contributions to drug regulation and public policy have contributed to the development of medicines and other approaches for behavioral and CNS disorders and improved public health. He focuses on abuse liability and Controlled Substances Act (CSA) scheduling within the CSA Eight Factor Analysis of CNS-active substances. At NIDA, he led abuse potential assessments and developed drug scheduling recommendations in the Intramural Research Program in collaboration with FDA and DEA. He has contributed to comments to FDA on drug regulation and policy, and has written numerous books and monographs, and more than 500 published papers and reports for various governmental agencies and other organizations. His efforts have earned him a multitude of awards.